EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

The role of microchimerism in the development of endocrine diseases (using autoimmune thyroid diseases and type 1 diabetes mellitus as examples)

M V Alaverdova, E A Troshina

Problems of Endocrinology · 2026-03-07 · 72 (1) · 38-47

DOI: 10.14341/probl13636 ↗

At a glance

Übersichtsarbeit in Problems of Endocrinology, published online on 2026-03-07. Written by M V Alaverdova and 1 co-authors. Institution: Endocrinology research centre. Major MEDLINE topics: Diabetes Mellitus, Type 1, Chimerism, Thyroiditis, Autoimmune. Cited 1 times so far (Crossref); 60 references. The full text is freely available in PubMed Central. Funded by: Russian Ministry of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Microchimerism — the phenomenon of the presence of genetically foreign cells within the body — holds significant interest for endocrinology. It develops as a result of transplacental cell exchange during pregnancy (fetal and maternal microchimeric cells) or iatrogenic interventions and may play an important role in the development of autoimmune endocrine diseases. The greatest amount of data has been accumulated regarding thyroid diseases: fetal microchimeric cells are detected in 38–83% of cases of autoimmune thyroiditis and Graves’ disease, with their levels correlating with the activity of the autoimmune process. Three main hypotheses have been proposed regarding their involvement in pathogenesis: initiation of a "graft-versus-host" reaction postpartum, molecular mimicry with thyroid antigens, or passive accumulation in inflammatory foci. In type 1 diabetes mellitus, studies focus on maternal microchimeric cells, which are found in the pancreas of patients and can differentiate into β-cells; however, their pathogenic role remains controversial. Modern methods for detecting microchimeric cells — such as polymerase chain reaction (PCR) and immunofluorescent hybridization in situ (FISH) — are highly sensitive but require standardization. Promising research directions include studying the influence of HLA compatibility, long-term dynamics of microchimeric cells, and their potential therapeutic applications. Addressing these issues could lead to a revision of current understanding of the pathogenesis of endocrine diseases and the development of new treatment approaches.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 1ChimerismThyroiditis, AutoimmuneHumansFemalePregnancyMaternal-Fetal Exchange

Authors and institutions

  • Endocrinology research centre.

Funding

  • Russian Ministry of Health

Cite

APA

Alaverdova, M. V., & Troshina, E. A. (2026). The role of microchimerism in the development of endocrine diseases (using autoimmune thyroid diseases and type 1 diabetes mellitus as examples). Problems of Endocrinology, 72(1), 38-47. https://doi.org/10.14341/probl13636

Vancouver

Alaverdova MV, Troshina EA. The role of microchimerism in the development of endocrine diseases (using autoimmune thyroid diseases and type 1 diabetes mellitus as examples). Problems of Endocrinology. 2026;72(1):38-47. doi:10.14341/probl13636

BibTeX
@article{Alaverdova2026,
  author = {Alaverdova, M V and Troshina, E A},
  title = {The role of microchimerism in the development of endocrine diseases (using autoimmune thyroid diseases and type 1 diabetes mellitus as examples)},
  journal = {Problems of Endocrinology},
  year = {2026},
  volume = {72},
  number = {1},
  pages = {38--47},
  doi = {10.14341/probl13636}
}
Start for free →